Treatment of Bullous Impetigo
For bullous impetigo, topical mupirocin or retapamulin applied twice daily for 5 days is the recommended first-line treatment for limited disease, while oral antibiotics active against Staphylococcus aureus should be used for extensive disease or outbreaks. 1
Causative Organism
- Bullous impetigo is caused exclusively by Staphylococcus aureus strains that produce toxins cleaving the dermal-epidermal junction, forming fragile, thin-roofed vesicopustules 1, 2
- The lesions appear as flaccid bullae that may rupture, creating crusted, erythematous erosions 2
Treatment Recommendations
For Limited Disease
- Topical antibiotics are the first-line treatment for limited bullous impetigo 1, 3:
- Clinical efficacy rates for mupirocin are significantly higher than placebo (71% vs 35%) 3
- Mupirocin has shown similar or slightly superior efficacy compared to oral antibiotics in clinical trials 3, 4
For Extensive Disease
- Oral antibiotics are recommended for patients with numerous lesions or during outbreaks affecting multiple people 1, 5
- A 7-day regimen with an agent active against S. aureus is recommended 5, 1
- For methicillin-susceptible S. aureus (MSSA):
- For suspected or confirmed methicillin-resistant S. aureus (MRSA):
- Penicillin V is seldom effective and should not be used 2, 6
Special Considerations
- Topical disinfectants are inferior to antibiotics and should not be used 2, 4
- Monitor for clinical response within 24-48 hours when using oral antibiotics 1
- If progression occurs despite antibiotics, consider:
- Systemic antimicrobials should be used during outbreaks of post-streptococcal glomerulonephritis to eliminate nephritogenic strains from the community 5
- Resistance patterns should be considered when selecting empiric therapy, as there are increasing rates of resistance to commonly used antibiotics 2, 4
Treatment Algorithm
Assess extent of disease:
For limited disease:
For extensive disease:
If no improvement within 48 hours: